Janice Gabrilove

Mount Sinai Hospital — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

49h-index17.7kcitations244works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Retinoids in leukemia and cellular processes(39), Acute Myeloid Leukemia Research(38), Chronic Lymphocytic Leukemia Research(28), Neutropenia and Cancer Infections(27), Synthesis and Characterization of Heterocyclic Compounds(21)

Publications244 total

Design and implementation of a Targeted HealthcaRe InnoVation & Entrepreneurship (THRIVE) fellowship program
PLoS ONE·2025Open Access
Expedited diagnosis of disseminated <i>Mycobacterium kansasii</i> infection using targeted (amplicon-based) next-generation sequencing in an immunocompromised patient
ASM Case Reports·2025Open Access
Figure S5 from Arsenic Trioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD Acute Myeloid Leukemia Cells
2023Open Access
Figure S4 from Arsenic Trioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD Acute Myeloid Leukemia Cells
2023Open Access
Figure S1 from Arsenic Trioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD Acute Myeloid Leukemia Cells
2023Open Access
Figure S2 from Arsenic Trioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD Acute Myeloid Leukemia Cells
2023Open Access
Figure S4 from Arsenic Trioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD Acute Myeloid Leukemia Cells
2023Open Access
Figure S2 from Arsenic Trioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD Acute Myeloid Leukemia Cells
2023Open Access
Figure S3 from Arsenic Trioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD Acute Myeloid Leukemia Cells
2023Open Access
Figure S3 from Arsenic Trioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD Acute Myeloid Leukemia Cells
2023Open Access
Figure S1 from Arsenic Trioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD Acute Myeloid Leukemia Cells
2023Open Access
Data from Arsenic Trioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD Acute Myeloid Leukemia Cells
2023Open Access
Data from Arsenic Trioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD Acute Myeloid Leukemia Cells
2023Open Access
Figure S5 from Arsenic Trioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD Acute Myeloid Leukemia Cells
2023Open Access
Supplementary Figure 1 from Sorafenib Inhibition of Mcl-1 Accelerates ATRA-Induced Apoptosis in Differentiation-Responsive AML Cells
2023Open Access
Supplementary Figure 2 from Sorafenib Inhibition of Mcl-1 Accelerates ATRA-Induced Apoptosis in Differentiation-Responsive AML Cells
2023Open Access
Supplementary Figure Legends from Sorafenib Inhibition of Mcl-1 Accelerates ATRA-Induced Apoptosis in Differentiation-Responsive AML Cells
2023Open Access
Supplementary Figure 7 from Ethacrynic Acid and a Derivative Enhance Apoptosis in Arsenic Trioxide–Treated Myeloid Leukemia and Lymphoma Cells: The Role of Glutathione S-Transferase P1-1
2023Open Access
Supplementary Figure 3 from Ethacrynic Acid and a Derivative Enhance Apoptosis in Arsenic Trioxide–Treated Myeloid Leukemia and Lymphoma Cells: The Role of Glutathione S-Transferase P1-1
2023Open Access
Supplementary Figure Legend from Ethacrynic Acid and a Derivative Enhance Apoptosis in Arsenic Trioxide–Treated Myeloid Leukemia and Lymphoma Cells: The Role of Glutathione S-Transferase P1-1
2023Open Access
page 1 of 13Next →

Frequent Co-authors

Karl Welte(9), Ann A. Jakubowski(6), Raymond P. Warrell(5), David A. Scheinberg(5), E Platzer(5), Richard A. Larson(4), L M Souza(4), Malcolm A.S. Moore(4), Bayard Clarkson(4), Herbert F. Oettgen(4), Hagop M. Kantarjian(3), Roland Mertelsmann(3), Pier Paolo Pandolfi(3), Howard I. Scher(3), Mary Ann Bonilla(3), Peter L. Greenberg(3), Harry P. Erba(3), Andrea König(3), Michael R. Grever(3), Thomas J. Kipps(3)